HIGHLIGHTS
- who: SLEEPJ and colleagues from the DepartmentStanford University Pharmaceuticals, Chesterfield, MO, USA have published the research: SLEEPJ , 2022, 1-2, in the Journal: (JOURNAL)
SUMMARY
Published Response to: Once-nightly sodium oxybate (FT218) in the treatment of narcolepsy: a letter to the editor commenting on the recent publication by C. Kushida et_al | SLEEPJ, 2022, Vol. 45, No 6 consultant for Jazz Pharmaceuticals, Takeda Pharmaceutical Co. Orexo, Avadel Pharmaceuticals, Eisai, Merck and amp; Co., and Idorsia. C.M.S. is a consultant and has served on speakers bureaus for Avadel Pharmaceuticals and Jazz Pharmaceuticals . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.